Facebook
Linkedin
X
Website
Youtube
Sign in
Join
Click here - to use the wp menu builder
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
Search
Newspaper
DISCOVER THE ART OF PUBLISHING
Inhibrx provides clinical update on ozekibart in late line colorectal cancer
Louise Wilson-English
-
26 May 2026
US$ 8.5 million investment in malaria and other R&D projects planned...
Louise Wilson-English
-
26 May 2026
Positive phase 1 data for RAG-17 in amyotrophic lateral sclerosis patients...
Louise Wilson-English
-
26 May 2026
LATEST ARTICLES
New non-compromise early-phase progression accelerator launched
Louise Wilson-English
-
26 May 2026
AstraZeneca to seek accelerated approval of Ultomirisin in immunoglobulin A nephropathy...
Louise Wilson-English
-
26 May 2026
Tenvie doses first subject in phase 1 TNV108 trial for peripheral...
Louise Wilson-English
-
26 May 2026
Roche reports phase 3 study results for myelin oligodendrocyte glycoprotein antibody-associated...
Louise Wilson-English
-
26 May 2026
Interphex Week Tokyo 2026 organises show floor around manufacturing, packaging, inspection...
Louise Wilson-English
-
29 April 2026
Bio-Rad launches PTC Harmony 96 and PTC Harmony Deepwell thermal cyclers
Louise Wilson-English
-
29 April 2026
Evotec announces chief financial officer transition
Louise Wilson-English
-
29 April 2026
PCI Pharma Services announces US$1 billion expansion of US sterile fill-finish...
Louise Wilson-English
-
29 April 2026
ImmunoForge to accelerate central nervous system drug development with innovative blood-brain...
Louise Wilson-English
-
29 April 2026
Novo Nordisk to seek oral sickle cell therapy approval after phase...
Louise Wilson-English
-
29 April 2026
1
2
3
...
9
Page 1 of 9
